Literature DB >> 21430122

Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease.

Benjamin R Trible1, Maureen Kerrigan, Nicholas Crossland, Megan Potter, Kay Faaberg, Richard Hesse, Raymond R R Rowland.   

Abstract

Open reading frame 2 (ORF2) of porcine circovirus type 2 (PCV2) codes for the 233-amino-acid capsid protein (CP). Baculovirus-based vaccines that express only ORF2 are protective against clinical disease following experimental challenge or natural infection. The goal of this study was to identify regions in CP preferentially recognized by sera from experimentally infected and vaccinated pigs and to compare these responses to those of pigs diagnosed with porcine circovirus-associated disease (PCVAD), including porcine multisystemic wasting syndrome (PMWS) and porcine dermatitis and nephropathy syndrome (PDNS). The approach was to react porcine sera with CP polypeptide fragments followed by finer mapping studies using overlapping oligopeptides that covered amino acids 141 to 200. The results showed that vaccinated pigs preferentially recognized only the largest polypeptide fragment, CP(43-233). A subset of experimentally infected pigs and pigs with PDNS showed strong reactivity against a CP oligopeptide, 169-STIDYFQPNNKR-180. Alanine scanning identified Y-173, F-174, Q-175, and K-179 as important for antibody recognition. The results from this study support the notion of PCV2 modulation of immunity, including antibody responses that may represent a precursor for disease. The recognition of CP(169-180) and other polypeptides provides opportunities to devise diagnostic tests for monitoring the immunological effectiveness of vaccination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21430122      PMCID: PMC3122538          DOI: 10.1128/CVI.00418-10

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  52 in total

1.  Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes.

Authors:  D Mahé; P Blanchard; C Truong; C Arnauld; P Le Cann; R Cariolet; F Madec; E Albina; A Jestin
Journal:  J Gen Virol       Date:  2000-07       Impact factor: 3.891

2.  Nuclear localization of the ORF2 protein encoded by porcine circovirus type 2.

Authors:  Q Liu; S K Tikoo; L A Babiuk
Journal:  Virology       Date:  2001-06-20       Impact factor: 3.616

3.  Activation of the immune system is the pivotal event in the production of wasting disease in pigs infected with porcine circovirus-2 (PCV-2).

Authors:  S Krakowka; J A Ellis; F McNeilly; S Ringler; D M Rings; G Allan
Journal:  Vet Pathol       Date:  2001-01       Impact factor: 2.221

4.  Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein.

Authors:  Porntippa Nawagitgul; Igor Morozov; Steven R Bolin; Perry A Harms; Steven D Sorden; Prem S Paul
Journal:  J Gen Virol       Date:  2000-09       Impact factor: 3.891

5.  Postweaning multisystemic wasting syndrome induced after experimental inoculation of cesarean-derived, colostrum-deprived piglets with type 2 porcine circovirus.

Authors:  S R Bolin; W C Stoffregen; G P Nayar; A L Hamel
Journal:  J Vet Diagn Invest       Date:  2001-05       Impact factor: 1.279

Review 6.  Porcine circoviruses: a review.

Authors:  G M Allan; J A Ellis
Journal:  J Vet Diagn Invest       Date:  2000-01       Impact factor: 1.279

7.  Bacterial expression of an immunologically reactive PCV2 ORF2 fusion protein.

Authors:  Q Liu; P Willson; S Attoh-Poku; L A Babiuk
Journal:  Protein Expr Purif       Date:  2001-02       Impact factor: 1.650

8.  Replication of porcine circovirus type 1 requires two proteins encoded by the viral rep gene.

Authors:  A Mankertz; B Hillenbrand
Journal:  Virology       Date:  2001-01-20       Impact factor: 3.616

9.  Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins.

Authors:  M Fort; M Sibila; A Allepuz; E Mateu; F Roerink; J Segalés
Journal:  Vaccine       Date:  2008-01-07       Impact factor: 3.641

10.  Identification of an immunorelevant ORF2 epitope from porcine circovirus type 2 as a serological marker for experimental and natural infection.

Authors:  C Truong; D Mahe; P Blanchard; M Le Dimna; F Madec; A Jestin; E Albina
Journal:  Arch Virol       Date:  2001       Impact factor: 2.574

View more
  23 in total

1.  A single amino acid deletion in the matrix protein of porcine reproductive and respiratory syndrome virus confers resistance to a polyclonal swine antibody with broadly neutralizing activity.

Authors:  Benjamin R Trible; Luca N Popescu; Nicholas Monday; Jay G Calvert; Raymond R R Rowland
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

2.  Phylogenetic analysis of porcine circovirus type 2 (PCV2) between 2015 and 2018 in Henan Province, China.

Authors:  Guanmin Zheng; Qingxia Lu; Fangyu Wang; Guangxu Xing; Hua Feng; Qianyue Jin; Zhenhua Guo; Man Teng; Huifang Hao; Dongliang Li; Xin Wei; Yuhang Zhang; Ruiguang Deng; Gaiping Zhang
Journal:  BMC Vet Res       Date:  2020-01-07       Impact factor: 2.741

3.  Porcine circovirus genotypes and their copathogens in pigs with respiratory disease in southern provinces of Vietnam.

Authors:  Phat Xuan Dinh; Minh Nam Nguyen; Hien The Nguyen; Vu Hoang Tran; Quy Dinh Tran; Kim Hoang Dang; Dai Tan Vo; Hien Thanh Le; Nam Thi Thu Nguyen; Toan Tat Nguyen; Duy Tien Do
Journal:  Arch Virol       Date:  2021-01-03       Impact factor: 2.574

4.  Molecular genotypic analysis of porcine circovirus type 2 reveals the predominance of PCV2d in Vietnam (2018-2020) and the association between PCV2h, the recombinant forms, and Vietnamese vaccines.

Authors:  Huong Thi Thanh Doan; Roan Thi Do; Pham Thi Phuong Thao; Xuyen Thi Kim Le; Khue Thi Nguyen; Nguyen Thi Thu Hien; Luu Minh Duc; Linh Thi Khanh Pham; Thanh Hoa Le
Journal:  Arch Virol       Date:  2022-07-06       Impact factor: 2.685

5.  Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2.

Authors:  Benjamin R Trible; Andrew W Suddith; Maureen A Kerrigan; Ada G Cino-Ozuna; Richard A Hesse; Raymond R R Rowland
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

6.  Vaccination with a Porcine Reproductive and Respiratory Syndrome (PRRS) Modified Live Virus Vaccine Followed by Challenge with PRRS Virus and Porcine Circovirus Type 2 (PCV2) Protects against PRRS but Enhances PCV2 Replication and Pathogenesis Compared to Results for Nonvaccinated Cochallenged Controls.

Authors:  Megan C Niederwerder; Bhupinder Bawa; Nick V L Serão; Benjamin R Trible; Maureen A Kerrigan; Joan K Lunney; Jack C M Dekkers; Raymond R R Rowland
Journal:  Clin Vaccine Immunol       Date:  2015-10-07

7.  Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: A large scale epidemiological study.

Authors:  Giovanni Franzo; Claudia Maria Tucciarone; Mattia Cecchinato; Michele Drigo
Journal:  Sci Rep       Date:  2016-12-19       Impact factor: 4.379

Review 8.  Porcine Circovirus Type 2 (PCV2) Vaccines in the Context of Current Molecular Epidemiology.

Authors:  Anbu K Karuppannan; Tanja Opriessnig
Journal:  Viruses       Date:  2017-05-06       Impact factor: 5.048

9.  Structure analysis of capsid protein of Porcine circovirus type 2 from pigs with systemic disease.

Authors:  Danielle Gava; Vitor Hugo Balasco Serrão; Lana Teixeira Fernandes; Mauricio Egídio Cantão; Janice Reis Ciacci-Zanella; Nelson Morés; Rejane Schaefer
Journal:  Braz J Microbiol       Date:  2017-11-08       Impact factor: 2.476

10.  Recombinant expression of beak and feather disease virus capsid protein and assembly of virus-like particles in Nicotiana benthamiana.

Authors:  Guy L Regnard; Edward P Rybicki; Inga I Hitzeroth
Journal:  Virol J       Date:  2017-09-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.